Terms: = Bone cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
50 results:
1. Abdominopelvic desmoplastic small round cell tumor with metastasis: A case report and literature review.
Chen G; Zhang Q; Xia D
Medicine (Baltimore); 2024 Apr; 103(14):e37664. PubMed ID: 38579065
[TBL] [Abstract] [Full Text] [Related]
2. Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review.
Motallebzadeh Khanmiri J; Alizadeh M; Esmaeili S; Gholami Z; Safarzadeh A; Khani-Eshratabadi M; Baghbanzadeh A; Alizadeh N; Baradaran B
Cytotherapy; 2024 May; 26(5):427-435. PubMed ID: 38483358
[TBL] [Abstract] [Full Text] [Related]
3. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
[TBL] [Abstract] [Full Text] [Related]
4. Hypoplastic form of myelodysplastic neoplasm.
Votavová H; Lenertová Z; Votava T; Beličková M
Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
[TBL] [Abstract] [Full Text] [Related]
5. A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis.
Morris VS; Ghazi H; Fletcher DM; Guinn BA
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298623
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
7. Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.
Hosono N; Chi S; Yamauchi T; Fukushima K; Shibayama H; Katagiri S; Gotoh A; Eguchi M; Morishita T; Ogasawara R; Kondo T; Yanada M; Yamamoto K; Kobayashi T; Kuroda J; Usuki K; Utsu Y; Yoshimitsu M; Ishitsuka K; Ono T; Takahashi N; Iyama S; Kojima K; Nakamura Y; Fukuhara S; Izutsu K; Abutani H; Yamauchi N; Yuda J; Minami Y;
Cancer Sci; 2023 May; 114(5):2098-2108. PubMed ID: 36793248
[TBL] [Abstract] [Full Text] [Related]
8. High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients' samples.
Phikulsod P; Sukpanichnant S; Kunacheewa C; Chieochansin T; Junking M; Yenchitsomanus PT
Pathol Oncol Res; 2023; 29():1610844. PubMed ID: 36760714
[TBL] [Abstract] [Full Text] [Related]
9. Small round cell sarcomas.
Cidre-Aranaz F; Watson S; Amatruda JF; Nakamura T; Delattre O; de Alava E; Dirksen U; Grünewald TGP
Nat Rev Dis Primers; 2022 Oct; 8(1):66. PubMed ID: 36202860
[TBL] [Abstract] [Full Text] [Related]
10. Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant.
Chung DJ; Sharma S; Rangesa M; DeWolf S; Elhanati Y; Perica K; Young JW
Blood Adv; 2022 Mar; 6(5):1547-1558. PubMed ID: 35100339
[TBL] [Abstract] [Full Text] [Related]
11. Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia.
Cancio M; Hebert K; Kim S; Aljurf M; Olson T; Anderson E; Burroughs L; Vatsayan A; Myers K; Hashem H; Hanna R; Horn B; Prestidge T; Boelens JJ; Boulad F; Eapen M
Transplant Cell Ther; 2022 Feb; 28(2):101.e1-101.e6. PubMed ID: 34670170
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
[TBL] [Abstract] [Full Text] [Related]
13. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Holmberg-Thydén S; Dufva IH; Gang AO; Breinholt MF; Schejbel L; Andersen MK; Kadivar M; Svane IM; Grønbæk K; Hadrup SR; El Fassi D
Cancer Immunol Immunother; 2022 Feb; 71(2):433-444. PubMed ID: 34218294
[TBL] [Abstract] [Full Text] [Related]
15. Galinpepimut-S (GPS): an investigational agent for the treatment of acute myeloid leukemia.
Jain AG; Talati C; Pinilla-Ibarz J
Expert Opin Investig Drugs; 2021 Jun; 30(6):595-601. PubMed ID: 34053383
[No Abstract] [Full Text] [Related]
16. Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Deng DX; Wen JJ; Cheng YF; Zhang XH; Xu LP; Wang Y; Yan CH; Chen YH; Chen H; Han W; Wang FR; Wang JZ; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
BMC Cancer; 2021 Mar; 21(1):292. PubMed ID: 33740924
[TBL] [Abstract] [Full Text] [Related]
17. TP-0903 is active in models of drug-resistant acute myeloid leukemia.
Jeon JY; Buelow DR; Garrison DA; Niu M; Eisenmann ED; Huang KM; Zavorka Thomas ME; Weber RH; Whatcott CJ; Warner SL; Orwick SJ; Carmichael B; Stahl E; Brinton LT; Lapalombella R; Blachly JS; Hertlein E; Byrd JC; Bhatnagar B; Baker SD
JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268594
[TBL] [Abstract] [Full Text] [Related]
18. bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
Danziger SA; McConnell M; Gockley J; Young MH; Rosenthal A; Schmitz F; Reiss DJ; Farmer P; Alapat DV; Singh A; Ashby C; Bauer M; Ren Y; Smith K; Couto SS; van Rhee F; Davies F; Zangari M; Petty N; Orlowski RZ; Dhodapkar MV; Copeland WB; Fox B; Hoering A; Fitch A; Newhall K; Barlogie B; Trotter MWB; Hershberg RM; Walker BA; Dervan AP; Ratushny AV; Morgan GJ
PLoS Med; 2020 Nov; 17(11):e1003323. PubMed ID: 33147277
[TBL] [Abstract] [Full Text] [Related]
19. Wilm's Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantation.
Rautenberg C; Bergmann A; Pechtel S; Fischermanns C; Haas R; Germing U; Kobbe G; Schroeder T
Bone Marrow Transplant; 2021 Feb; 56(2):442-450. PubMed ID: 32873914
[TBL] [Abstract] [Full Text] [Related]
20. wt1, PRAME, and PR3 mRNA Expression in Acute Myeloid Leukemia (AML).
Steger B; Floro L; Amberger DC; Kroell T; Tischer J; Kolb HJ; Schmetzer HM
J Immunother; 2020; 43(6):204-215. PubMed ID: 32502139
[TBL] [Abstract] [Full Text] [Related]
[Next]
